Selective denervation of the corrugator supercilii muscle for the treatment of idiopatic trigeminal neuralgia purely paroxysmal distributed in the supraorbital and suprathrochlear dermatomes.
Botulinum toxin type a
Headache disorders
Migraine disorders
Neuralgia
Quality of life
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
04 Mar 2021
04 Mar 2021
Historique:
received:
05
01
2021
accepted:
15
02
2021
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
9
3
2021
Statut:
epublish
Résumé
Idiopatic trigeminal neuralgia purely paroxysmal (ITNp) distributed in the supraorbital and suprathrochlear dermatomes (SSd), refractory to conventional treatments have been linked to the hyperactivity of the corrugator supercilii muscle (CSM). In these patients, the inactivation of the CSM via botulinum toxin type A (BTA) injections has been proven to be safe and effective in reducing migraine burden. The main limitation of BTA is the need of repetitive injections and relative high costs. Based on the study of the motor innervation of the CSM, we describe here an alternative approach to improve these type of migraines, based on a minimally invasive denervation of the CSM. Motor innervation and feasibility of selective CSM denervation was first studied on fresh frozen cadavers. Once the technique was safely established, 15 patients were enrolled. To be considered eligible, patients had to meet the following criteria: positive response to BTA treatment, migraine disability assessment score > 24, > 15 migraine days/month, no occipital/temporal trigger points and plausible reasons to discontinue BTA treatment. Pre- and post- operative migraine headache index (MHI) were compared, and complications were classified following the Clavien-Dindo classification (CDC). Fifteen patients (9 females and 6 males) underwent the described surgical procedure. The mean age was 41 ± 10 years. Migraine headache episodes decreased from 24 ± 4 day/month to 2 ± 2 (p < 0.001) The MHI decreased from 208 ± 35 to 10 ± 11 (p < 0.001). One patient (7%) had a grade I complication according to the CDC. No patient needed a second operative procedure. Our findings suggest that the selective CSM denervation represents a safe and minimally invasive approach to improve ITNp distributed in the SSd associated with CSM hyperactivation. The data collection was conducted as a retrospective quality assessment study and all procedures were performed in accordance with the ethical standards of the national research committee and the 1964 Helsinki Declaration and its later amendments.
Identifiants
pubmed: 33663369
doi: 10.1186/s10194-021-01218-6
pii: 10.1186/s10194-021-01218-6
pmc: PMC7931360
doi:
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9Références
Aesthetic Plast Surg. 2017 Feb;41(1):40-46
pubmed: 28032176
J Laryngol Otol. 2009 Apr;123(4):412-7
pubmed: 18588738
Dermatol Surg. 2015 Jan;41(1):87-93
pubmed: 25521099
J Clin Psychiatry. 2014 Aug;75(8):837-44
pubmed: 24910934
Curr Pain Headache Rep. 2019 Mar 4;23(3):18
pubmed: 30830462
Plast Reconstr Surg. 2008 Jan;121(1):233-240
pubmed: 18176226
Headache. 2003 Sep;43(8):853-60
pubmed: 12940806
Plast Reconstr Surg. 2013 Apr;131(4):743-750
pubmed: 23249981
Aesthetic Plast Surg. 2017 Apr;41(2):339-345
pubmed: 28233129
Headache. 1989 Oct;29(9):598-600
pubmed: 2584002
Plast Reconstr Surg. 2004 Sep 1;114(3):652-7; discussion 658-9
pubmed: 15318040
Curr Pain Headache Rep. 2010 Aug;14(4):321-4
pubmed: 20499214
Plast Reconstr Surg. 2012 Feb;129(2):413-419
pubmed: 21987048
J Headache Pain. 2015 Jan 26;16:5
pubmed: 25623151
Ann Plast Surg. 2004 Feb;52(2):140-3
pubmed: 14745262
Plast Reconstr Surg. 2007 Nov;120(6):1647-1653
pubmed: 18040200
Plast Reconstr Surg. 2001 Feb;107(2):604-5; discussion 606-7
pubmed: 11214082
Plast Reconstr Surg. 2000 Aug;106(2):429-34; discussion 435-7
pubmed: 10946944
Plast Reconstr Surg. 2010 Mar;125(3):879-89
pubmed: 20195114
Headache. 2003 Nov-Dec;43(10):1085-9
pubmed: 14629244
Plast Reconstr Surg Glob Open. 2016 Jul 12;4(7):e795
pubmed: 27536474
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Toxins (Basel). 2015 Jul 17;7(7):2629-38
pubmed: 26193317
J Plast Reconstr Aesthet Surg. 2006;59(4):366-72
pubmed: 16756251
Headache. 2015 Mar;55 Suppl 2:103-22; quiz 123-6
pubmed: 25662743
Cephalalgia. 2007 Sep;27(9):991-4
pubmed: 17727471
Plast Reconstr Surg. 2012 May;129(5):1113-1119
pubmed: 22544095
Plast Reconstr Surg. 2013 Apr;131(4):751-757
pubmed: 23542247
Plast Reconstr Surg. 2012 Apr;129(4):656e-662e
pubmed: 22456379
J Craniofac Surg. 2016 Jul;27(5):1331-5
pubmed: 27300459
J Craniofac Surg. 2017 Nov;28(8):e720
pubmed: 28906332
Qual Life Res. 2003 Dec;12(8):1003-12
pubmed: 14651418